Connect-Home: Alzheimer's Disease and Related Dementias

Description

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Conditions

Alzheimer Disease, Dementia

Study Overview

Study Details

Study overview

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial

Connect-Home: Alzheimer's Disease and Related Dementias

Condition
Alzheimer Disease
Intervention / Treatment

-

Contacts and Locations

Chapel Hill

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States, 27599

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Ability to speak English
  • * Goal of discharge to home, assisted living, or long-term care
  • * Diagnosis of dementia
  • * Having a caregiver willing to participate
  • * Ability to speak English
  • * Legally authorized representative (LAR) who also provides support for the person with ADRD
  • * Location within 120 miles of UNC-Chapel Hill
  • * Admission of at least 75 SNF patients per year
  • * Planned hospital readmission for procedures or treatments within 30 days post enrollment.
  • * LAR is a court-appointed guardian.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of North Carolina, Chapel Hill,

Mark Toles, PhD, RN, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

2027-06-30